Thomas J. Herzfeld Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$61,880
-1.5%
4,0000.0%0.02%
-4.0%
Q2 2023$62,840
-4.7%
4,0000.0%0.02%
-7.4%
Q1 2023$65,920
+5.6%
4,0000.0%0.03%
+3.8%
Q4 2022$62,400
+20.0%
4,0000.0%0.03%
+18.2%
Q3 2022$52,000
-7.1%
4,0000.0%0.02%
-4.3%
Q2 2022$56,000
-1.8%
4,0000.0%0.02%
+9.5%
Q1 2022$57,000
+3.6%
4,0000.0%0.02%
+5.0%
Q4 2021$55,000
-16.7%
4,0000.0%0.02%
-31.0%
Q3 2021$66,000
-1.5%
4,0000.0%0.03%
+3.6%
Q2 2021$67,000
-8.2%
4,0000.0%0.03%
-15.2%
Q1 2021$73,0000.0%4,0000.0%0.03%
-2.9%
Q4 2020$73,000
+17.7%
4,0000.0%0.03%
-19.0%
Q3 2020$62,000
-15.1%
4,0000.0%0.04%
+16.7%
Q2 2020$73,000
+12.3%
4,000
-6.5%
0.04%
+2.9%
Q1 2020$65,000
-22.6%
4,2790.0%0.04%
+16.7%
Q4 2019$84,000
+13.5%
4,2790.0%0.03%
+11.1%
Q3 2019$74,000
-5.1%
4,279
-2.7%
0.03%
-10.0%
Q2 2019$78,000
-3.7%
4,396
+9.9%
0.03%0.0%
Q1 2019$81,000
+20.9%
4,0000.0%0.03%
+11.1%
Q4 2018$67,0004,0000.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders